EXCLUSION
CRITERIA:
1.
Patients
who refused Subarachnoid Block procedure
2.
Patients
receiving thromboprophylaxis
3.
Patients
having Allergy to local anaesthetics
4.
Infection at the site of procedure
5.
Obstetric population
6.
Patients with spina bifida
7.
Patients with Aortic stenosis, mitral
stenosis, mitral regurgitation
8.
Patients with raised intracranial
tension
9.
Patients with inherited and acquired
coagulopathies
STUDY METHODOLOGY
We
will perform a prospective randomized controlled study on all the patients who
will be included in the study after taking institutional ethical committee
approval.
Patients
will be randomized into 3 groups using computer generated random number table:
Group
A (n=20) - Patients undergoing sub arachnoid block under guidance of
ultrasonography
Group
B (n=20) - Patients undergoing sub arachnoid block under fluoroscopic c arm
guidance
Group
C (n=20) - Patients undergoing sub arachnoid block using anatomical landmark guided
technique
To achieve adequate expertise, we will perform ultrasound
guided subarachnoid block and
c-arm fluoroscopy
guided subarachnoid block on 25-25 normal patients who are posted for
infraumbilical surgeries respectively before starting the study.
Pre-anaesthetic
check-up including detailed history, general examination, systemic examination
of cardiovascular, respiratory, central nervous system and for systemic illness
will be done. Patients
will be explained about concerned procedure, written and informed consent will be taken after
explaining the procedure. Patients will be instructed to keep fasting for 6-8 hours
on the day before surgery.
After shifting the patients to operation theatre heart rate,
non-invasive blood pressure, oxygen saturation (spo2), electrocardiogram
(ECG) will be monitored.
In operation theatre peripheral vascular access will be secured with 18-gauge (G)
intravenous cannula in all patients and Ringer Lactate infusion will be started.
Patients of all 3 groups will be administered with injection Ondansetron 4 mg
iv and Injection ranitidine
50mg iv. Subarachnoid
block will be performed by the person who will be involved in the study and all
the observations will be recorded by the person who is not involved in the
study.
Total procedure time is defined as Time
taken to identify the landmark by each technique followed by administration of
drug in subarachnoid space. Number of needle insertion attempts is defined as
number of any separate skin puncture by a needle. Success rate
is defined as successful dural puncture followed by free flow of cerebrospinal
fluid.
Patient
satisfaction score with the block procedure is rated by patient immediately
after completion of subarachnoid block on 5-point Likert scale
(5= very
satisfied, 4= satisfied,
3=
enough satisfied, 2= dissatisfied, 1= very dissatisfied)
PROCEDURE
All
patients will be placed in sitting position under routine monitoring. Under all aseptic precautions,
the desired Intervertebral space will be identified by manual palpation of
anatomical Landmark. A horizontal imaginary line passing over top of both iliac
crests which is known as tuffiers line corresponding to (L4-L5) intervertebral
space will be taken as guide to identify the space.
GROUP
A
The
ultrasound probe will be covered with sterile sleeve and sterile gel applied on
the probe. After positioning probe at
the sacrum, the probe will be directed from caudal to cephalad direction to
identify the successive intervertebral laminas (L5, L4, L3, and so on). The L4-L5
intervertebral spaces
will be identified on this plane and marked on the skin. The distance
from skin to intrathecal space will be measured and recorded, following which skin around L4-L5 Intervertebral
space will be infiltrated with 2% Lidocaine. A 25G 90mm
long Quincke’s spinal needle will be inserted in L4-L5 intervertebral space and needle tip will be advanced under
real time ultrasound guidance and the direction of the needle shaft will be
adjusted under ultrasound guidance to enter the subarachnoid space. After
confirmation of the free flow of cerebrospinal fluid, inj. Bupivacaine 0.5%
hyperbaric (0.3mg/kg) will be injected into subarachnoid space.
GROUP B
Skin around L4-L5 intervertebral
space will be infiltrated with 2% lidocaine following which fluoroscopy C-arm
machine will be positioned over lumbar spine with appropriate
x ray views will be taken. A 25gauge 90mm long
Quincke’s spinal needle will be inserted in L4-L5 intervertebral space. Simultaneously
real time imaging with fluoroscopy c arm with series of x-ray images of lumbar
spine will be done and the shaft of the needle will be adjusted accordingly
till free flow of cerebrospinal fluid comes out. Inj. Bupivacaine 0.5%
hyperbaric (0.3mg/kg) will be injected into sub arachnoid space.
GROUP
C
The
skin around L4-L5 Intervertebral space will be infiltrated with 2% lidocaine, following
which 25gauge 90mm long Quincke’s spinal needle will be inserted in (L4-L5)
intervertebral space. Successful
entry of needle into sub arachnoid space will be confirmed by free flow of cerebrospinal
fluid from the needle hub, after which inj. Bupivacaine 0.5% hyperbaric (0.3mg/kg)
will be injected into sub arachnoid space. All the patients will be immediately
placed in supine position after giving subarachnoid block.
Successful spinal anaesthesia will be
defined as bilateral T6 block after intrathecal drug administration.
Hemodynamic parameters, heart rate (HR), systolic
blood pressure (SBP),
diastolic pressure (DBP), Mean arterial
pressure (MAP), respiratory rate (RR),
oxygen saturation (SPO2) will be
monitored throughout the surgery.
Outcome variables:
Total procedure time is defined
as time taken to identify the landmarks by each technique upto free flow of
cerebrospinal fluid
Number of needle insertion attempts is defined
as number of any separate skin puncture by a needle.
Success rate is defined
as successful dural puncture followed by free flow of cerebrospinal fluid.
Failure is defined
as failure of localization of subarachnoid space with lumbar puncture in three
needle insertion attempts
Patient satisfaction score with the
block procedure is rated by patient immediately after completion of procedure
on
5-point Likert scale (5= very
satisfied, 4= satisfied, 3= enough satisfied, 2= dissatisfied, 1= very
dissatisfied)